Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
16%
OVERLAP
BY WEIGHT
35
# OF OVERLAPPING
HOLDINGS
IBBQ
207
HOLDINGS
17%
ALSO IN CANC
CANC
53
HOLDINGS
66%
ALSO IN IBBQ
SECTOR DRIFT (IBBQ minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 7.6% | 2.2% | 2.2% |
|
GILEAD SCIENCES INC | 7.4% | 2.0% | 2.0% |
|
SUMMIT THERAPEUTICS INC | 1.4% | 1.5% | 1.4% |
 |
ARGENX SE ADR | 2.2% | 1.1% | 1.1% |
|
REGENERON PHARMACEUTICALS | 5.5% | 1.1% | 1.1% |
IBBQ Overweight Relative to CANC
|
VERTEX PHARMACEUTICALS INC | 7.6% |
|
AMGEN INC | 5.5% |
|
GILEAD SCIENCES INC | 5.4% |
|
ALNYLAM PHARMACEUTICALS INC | 5.3% |
|
REGENERON PHARMACEUTICALS | 4.5% |
 |
ASTRAZENECA PLC-SPONS ADR | 3.9% |
|
INSMED INC | 3.0% |
|
BIOGEN IDEC INC | 2.1% |
|
UNITED THERAPEUTICS CORP | 1.8% |
|
INCYTE CORP | 1.5% |
IBBQ Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.5% |
|
ELI LILLY & CO | -5.1% |
|
ASTRAZENECA PLC | -4.3% |
 |
NOVARTIS AG | -4.1% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.9% |
|
COGENT BIOSCIENCES INC | -3.7% |
 |
GENMAB A/S SPONSORED ADR | -3.6% |
|
BRIDGEBIO PHARMA, INC. | -3.5% |
|
BRISTOL-MYERS SQUIBB CO | -3.4% |
|
JOHNSON & JOHNSON | -3.2% |